SLAISOLAI Limited
This year, SLAI has to prove it’s not just surviving but evolving — and the next catalyst is the 2026-10-15 listing compliance and potential reverse split decision, which could either reset the stock’s trajectory toward $1.05 or send it plummeting toward $0.50, depending on whether management can pair any action with credible operational progress. The path forward is narrow, and the market is watching for signs that SLAI is more than a distressed tech name.
The schedule
- Thu15Oct
If SLAI continues to trade around or below $0.65 through late 2026, the board may need to address listing compliance, where a proactive reverse split and clearer communication around strategy could help lift the stock closer to $1.05, while inaction or a poorly messaged move could push it toward $1.05.
- Thu19Nov
- Mon15Mar
The FY 2026 annual report and auditor’s opinion around a base of $1.40 will crystallize views on SLAI’s solvency and long-term viability, where clean financials, extended cash runway, and reduced reliance on frequent capital raises could support a recovery toward $1.60, whereas a going-concern warning or strained liquidity could anchor the stock closer to $0.60.
- Sun22Aug
Q3 2026 results and early commentary on the 2027 demand environment from a base around $0.50 will be a key inflection point, with confirmation of a sustainable revenue base and tightening losses potentially driving a recovery toward $1.40, while continued weakness or lack of bookings visibility may keep the stock capped near $0.70 despite its depressed valuation.
Past
- Thu20Aug
The Q2 2026 earnings release around $0.95 will test whether earlier quarters marked a true trough in revenue, with evidence of stabilization in IT services and AI-related contracts potentially re-rating the stock toward $1.25, whereas another step down in the run-rate or a lack of bookings visibility could leave shares stuck closer to $0.65.
- Wed15Jul
Actual outcome: Bull
SOLAI received a delisting notice from the NYSE, prompting the company to schedule an Extraordinary General Meeting to address its compliance and balance sheet issues. Despite the distressed nature of the delisting proceedings, the stock's recorded price closed at $3.15, well above the $0.95 bull target, likely reflecting structural share adjustments such as a reverse split or speculative positioning around the company's strategic response.
Given limited cash generation and a sub-$50m enterprise value, the market will be watching mid-2026 for a potential equity raise or other balance sheet transaction, where a well-structured financing that extends runway could keep the stock around $0.95 while a highly dilutive or distressed deal could drag it toward $0.95 from a base of about $1.10.
- Wed20May
Actual outcome: Bull · $3.36 at outcome
SOLAI Limited reported in-line Q1 2026 earnings with an EPS of -$0.96, matching analyst estimates, alongside the immediate commercial availability of its Solode Neo device. Despite receiving a continued listing standard notice from the NYSE, the stock rallied as investors cheered the strategic rollout of Solode Neo, which now supports major AI models like Hermes, Claude Code, OpenAI Codex, and Gemini CLI via over-the-air updates. This significant expansion of the company's personal AI infrastructure capabilities provided a strong positive outlook reset, driving bullish sentiment that overshadowed the listing compliance concerns.
Q1 2026 results and management commentary on the sharp revenue decline and path back to sustainable growth will be a major binary catalyst around $0.85, with a constructive reset and credible cost discipline potentially lifting the stock toward $1.10 while further deterioration or weak guidance could push it down toward $1.10.
